http://www.pharmaceuticalproductguide.com/blog A comprehensive guide to pharmaceutical products for medical professionals Fri, 11 Jun 2010 09:15:33 +0000 http://wordpress.org/?v=2.8.2 en hourly 1 http://www.pharmaceuticalproductguide.com/blog/2009/12/04/bristol-myers-abilify-to-treat-irritabilty-in-pediatric-patients-with-autistic-disorder-gets-fda-approval/ http://www.pharmaceuticalproductguide.com/blog/2009/12/04/bristol-myers-abilify-to-treat-irritabilty-in-pediatric-patients-with-autistic-disorder-gets-fda-approval/#comments Fri, 04 Dec 2009 14:50:51 +0000 Kimberly O'Brien http://www.pharmaceuticalproductguide.com/blog/?p=167 Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co., Ltd. said that FDA has approved the supplemental New Drug Application or sNDA for Abilify for the treatment of irritability associated with autistic disorder in pediatric patients of ages 6 to 17 years. The approval of Abilify for the treatment of irritation in patients with autistic disorder in pediatric patients is based on data from two eight-week, randomized, double-blind, placebo-controlled, multi-center, Phase III studies.

]]> http://www.pharmaceuticalproductguide.com/blog/2009/12/04/bristol-myers-abilify-to-treat-irritabilty-in-pediatric-patients-with-autistic-disorder-gets-fda-approval/feed/ 0